Register entry
- Registered sites
- 0
- Active NDC listings
- 5
- Labeller names
- 2
- Live patents
- 6
- Countries
- 0
Catalogue
Drug listings by form and route
55 active NDC listings: 5 human prescription drug. By marketing category: NDA 5.
| Dosage form | NDCs |
|---|---|
| kit | 3 |
| tablet, film coated | 2 |
| Route | NDCs |
|---|---|
| oral | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| averitas pharma inc | 3 |
| averitas pharma, inc. | 2 |
Exclusivity
Patents and exclusivities
6| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7786133 | MOVANTIKnaloxegol oxalate | substance, product | Sept 2028 |
| 9226903 | QUTENZAcapsaicin | product | Dec 2028 |
| 8821920 | QUTENZAcapsaicin | product | Mar 2030 |
| 9012469 | MOVANTIKnaloxegol oxalate | substance, product | Apr 2032 |
Catalogue
Marketed products
5| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| MOVANTIK | naloxegol oxalate | tablet, film coated, oral | 82625-8801NDA |
| MOVANTIK | naloxegol oxalate | tablet, film coated, oral | 82625-8802NDA |
| Qutenza | capsaicin | kit | 72512-928NDA |
| Qutenza | capsaicin | kit | 72512-929NDA |
| Qutenza | capsaicin | kit | 72512-930NDA |
Compare
Other companies listing capsaicin
- Mentholatum Company, The5 sites · 108 NDC
- Sato Pharmaceutical Co., Ltd.1 site · 33 NDC
- Universal Distribution Center LLC0 sites · 89 NDC
Enquiry
Common questions
- Is Averitas Pharma, Inc. FDA approved?
- Averitas Pharma, Inc. holds no registered establishment of its own; 5 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Averitas Pharma, Inc. make?
- 5 products are listed under Averitas Pharma, Inc. in the openFDA NDC Directory, most often as kit; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.